Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Roche
Company Monitoring Page for Roche
latest headlines for company on cafepharma
Lung Cancer Takes Center Stage at ESMO Congress 2023 With New Drugs, More Options
OBR Oncology
Fri, 10/20/23 - 10:05 am
Tags:
ESMO
,
non-small cell lung cancer
,
Roche
,
Alecensa
,
AstraZeneca
,
Tagrisso
,
JNJ
,
Rybrevant
Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific
Fierce Biotech
Thu, 10/19/23 - 11:36 am
Tags:
Roche
,
diabetic retinopathy
,
solid tumors
,
bispecific antibodies
Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales
Reuters
Thu, 10/19/23 - 10:03 am
Tags:
Roche
,
earnings
,
Vabysmo
Roche pays $50M upfront to Monte Rosa in molecular glue deal
Fierce Biotech
Tue, 10/17/23 - 09:46 pm
Tags:
Roche
,
molecular glue
,
Monte Rosa
,
QuEEN
,
protein degradation
Roche builds gene therapy portfolio with SpliceBio deal
Pharmaphorum
Tue, 10/17/23 - 11:00 am
Tags:
Roche
,
Spark Therapeutics
,
SpliceBio
,
gene therapy
,
inherited retinal disease
Amid Eylea showdown, Roche's Vabysmo shows durability in retinal vein occlusion
Fierce Pharma
Wed, 10/11/23 - 10:13 am
Tags:
Roche
,
retinal vein occlusion
,
Vabysmo
Roche preps for filings after subcutaneous Ocrevus matches up to IV formulation in phase 3 study
Fierce Pharma
Wed, 10/11/23 - 10:07 am
Tags:
Roche
,
Ocrevus
,
MS
,
multiple sclerosis
,
clinical trials
Majority of Newborn Babies With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Able to Sit Independently After 1 Year of Treatment
BioSpace
Wed, 10/4/23 - 09:41 am
Tags:
Roche
,
Genentech
,
clinical trials
,
Evrysdi
,
SMA
Biogen nabs FDA nod for biosimilar version of Roche's blockbuster Actemra
Fierce Pharma
Mon, 10/2/23 - 11:48 am
Tags:
Biogen
,
Roche
,
Actemra
,
autoimmune disease
,
biosimilars
In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset
Fierce Pharma
Fri, 09/29/23 - 12:13 pm
Tags:
AbbVie
,
Roche
,
Venclexta
,
Multiple Myeloma
Roche pays Ionis $60M upfront to license RNA-targeting Alzheimer's, Huntington's programs
Fierce Biotech
Wed, 09/27/23 - 10:14 am
Tags:
Roche
,
Ionis Pharmaceuticals
,
RNA
,
Alzheimer's disease
,
Huntington's disease
Roche condemns 'act of counterfeiting' as authorities in Pakistan crack down on unapproved Avastin use
Fierce Pharma
Mon, 09/25/23 - 07:42 pm
Tags:
Roche
,
Avastin
,
Pakistan
,
drug counterfeiting
Roche scores—again—in hemophilia drug patent case against Takeda
Fierce Pharma
Thu, 09/21/23 - 11:47 am
Tags:
Roche
,
Takeda
,
patents
,
legal
,
Genentech
,
Baxalta
,
hemophilia
Roche hits FDA delay with subcutaneous version of Tecentriq amid manufacturing process changes
Fierce Pharma
Thu, 09/7/23 - 10:53 pm
Tags:
Roche
,
FDA
,
Tecentriq
,
Halozyme
Roche Sees Return on $310M Investment with Alnylam’s Phase II Hypertension Win
BioSpace
Thu, 09/7/23 - 10:49 pm
Tags:
Alnylam
,
Roche
,
PAH
,
zilebesiran
,
clinical trials
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
Tags:
R&D
,
biotech
,
Merck
,
sotatercept
,
Daiichi Sankyo
,
AstraZeneca
,
Dato-DXd
,
Novo Nordisk
,
CagriSema
,
Eli Lilly
,
donanemab
,
Karuna Therapeutics
,
Zai Lab
,
KarXT
,
Moderna Therapeutics
,
mRNA-1647
,
Novartis
,
iptacopan
,
Madrigal Pharmaceuticals
,
resmetirom
,
Cytokinetics
,
aficamten
,
Roche
,
Chugai
,
tiragolumab
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
Tags:
FDA
,
Sandoz
,
Novartis
,
Gilead Sciences
,
Pfizer
,
Neurocrine
,
Regeneron
,
Ipsen
,
Revance Therapeutics
,
Delcath Systems
,
Janssen
,
Galera Therapeutics
,
Biogen
,
Roche
,
Mesoblast
,
Taiho Oncology
Merck’s Keytruda to top drug sales in 2028, as Roche takes pharma crown
Medical Marketing and Media
Fri, 08/25/23 - 09:55 am
Tags:
Merck
,
Keytruda
,
Roche
,
branding
Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors
BioSpace
Thu, 08/24/23 - 11:50 am
Tags:
Roche
,
Genentech
,
divarasib
,
KRAS inhibitors
,
solid tumors
,
clinical trials
Roche, Horizon lead way for pharma reputation among rare disease patient groups
Medical Marketing and Media
Wed, 08/23/23 - 05:49 pm
Tags:
Roche
,
Horizon Pharma
,
reputation
,
rare disease
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.